Cargando…

Clinical Characteristics, Antimicrobial Resistance, and Outcomes of Patients with Invasive Pneumococcal Disease in Ningxia Hui Autonomous Region, China, 2013–2021

OBJECTIVES: This study aimed to analyze the clinical features, antibiotic susceptibility profiles, and outcomes of patients with invasive pneumococcal disease (IPD) at a hospital in Ningxia Hui Autonomous Region, to provide the basis for improving the clinical treatment effect. METHODS: Patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Jia, Wang, Wen, Li, Gang, Wang, Linlin, Wang, Liang, Zhao, Zhijun, Jia, Wei, Wang, Liru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763006/
https://www.ncbi.nlm.nih.gov/pubmed/36545503
http://dx.doi.org/10.1155/2022/1262884
_version_ 1784852964099227648
author Tao, Jia
Wang, Wen
Li, Gang
Wang, Linlin
Wang, Liang
Zhao, Zhijun
Jia, Wei
Wang, Liru
author_facet Tao, Jia
Wang, Wen
Li, Gang
Wang, Linlin
Wang, Liang
Zhao, Zhijun
Jia, Wei
Wang, Liru
author_sort Tao, Jia
collection PubMed
description OBJECTIVES: This study aimed to analyze the clinical features, antibiotic susceptibility profiles, and outcomes of patients with invasive pneumococcal disease (IPD) at a hospital in Ningxia Hui Autonomous Region, to provide the basis for improving the clinical treatment effect. METHODS: Patients with IPD were retrospectively collected from 2013 to 2021. Clinical manifestations, laboratory tests, antimicrobial susceptibility, antibiotic treatment, and outcomes of the disease were analyzed. RESULTS: In this study, we identified 127 IPD cases, of whom 49 (38.6%) had meningitis and 78 (61.4%) had bacteremia. The median ages of pediatric cases and adult cases were 2 years (IQR: 0–5) and 52.5 years (IQR: 35–62), respectively. There were 27 and 45 males in the pediatric and adult groups, and no significant gender difference in the different age groups (p = 0.584) was found. Of 75 cases with underlying diseases, pneumonia (11%), malignancy (11%), hypertension (9.4%), and hepatic cirrhosis (7.9%) were the most common. The incidence of underlying diseases was even higher in the adult group (67.1%) than in the pediatric group (47.1%) (p = 0.028). The frequency of fever, cough, and seizures was significantly higher in the pediatric group than in the adult group, with p-values of 0.004, 0.004, and 0.001, respectively. The percentage of neutrophils in the blood was significantly higher in the adult cases than in the pediatric cases (p  <  0.001). Furthermore, there was a significantly higher WBC count (p  <  0.001), percentage of neutrophils (p = 0.012), and protein level (p = 0.019) in the CSF samples in the adult patients compared to pediatric patients. The susceptibility rates of S. pneumoniae isolates to vancomycin, linezolid, and levofloxacin were 100%. The susceptibility rates of penicillin were 98.7% and 34.1% in bacteremia and meningitis patients, respectively. Most isolates were resistant to erythromycin, clindamycin, tetracycline, and azithromycin. The most common antibiotic treatment was β-lactams. Seven (5.5%) patients died during hospitalization, and 38 (29.9%) patients' health deteriorated. CONCLUSION: These results may provide a reference basis for the diagnosis and empiric treatment of IPD in the region.
format Online
Article
Text
id pubmed-9763006
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-97630062022-12-20 Clinical Characteristics, Antimicrobial Resistance, and Outcomes of Patients with Invasive Pneumococcal Disease in Ningxia Hui Autonomous Region, China, 2013–2021 Tao, Jia Wang, Wen Li, Gang Wang, Linlin Wang, Liang Zhao, Zhijun Jia, Wei Wang, Liru Can J Infect Dis Med Microbiol Research Article OBJECTIVES: This study aimed to analyze the clinical features, antibiotic susceptibility profiles, and outcomes of patients with invasive pneumococcal disease (IPD) at a hospital in Ningxia Hui Autonomous Region, to provide the basis for improving the clinical treatment effect. METHODS: Patients with IPD were retrospectively collected from 2013 to 2021. Clinical manifestations, laboratory tests, antimicrobial susceptibility, antibiotic treatment, and outcomes of the disease were analyzed. RESULTS: In this study, we identified 127 IPD cases, of whom 49 (38.6%) had meningitis and 78 (61.4%) had bacteremia. The median ages of pediatric cases and adult cases were 2 years (IQR: 0–5) and 52.5 years (IQR: 35–62), respectively. There were 27 and 45 males in the pediatric and adult groups, and no significant gender difference in the different age groups (p = 0.584) was found. Of 75 cases with underlying diseases, pneumonia (11%), malignancy (11%), hypertension (9.4%), and hepatic cirrhosis (7.9%) were the most common. The incidence of underlying diseases was even higher in the adult group (67.1%) than in the pediatric group (47.1%) (p = 0.028). The frequency of fever, cough, and seizures was significantly higher in the pediatric group than in the adult group, with p-values of 0.004, 0.004, and 0.001, respectively. The percentage of neutrophils in the blood was significantly higher in the adult cases than in the pediatric cases (p  <  0.001). Furthermore, there was a significantly higher WBC count (p  <  0.001), percentage of neutrophils (p = 0.012), and protein level (p = 0.019) in the CSF samples in the adult patients compared to pediatric patients. The susceptibility rates of S. pneumoniae isolates to vancomycin, linezolid, and levofloxacin were 100%. The susceptibility rates of penicillin were 98.7% and 34.1% in bacteremia and meningitis patients, respectively. Most isolates were resistant to erythromycin, clindamycin, tetracycline, and azithromycin. The most common antibiotic treatment was β-lactams. Seven (5.5%) patients died during hospitalization, and 38 (29.9%) patients' health deteriorated. CONCLUSION: These results may provide a reference basis for the diagnosis and empiric treatment of IPD in the region. Hindawi 2022-12-12 /pmc/articles/PMC9763006/ /pubmed/36545503 http://dx.doi.org/10.1155/2022/1262884 Text en Copyright © 2022 Jia Tao et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tao, Jia
Wang, Wen
Li, Gang
Wang, Linlin
Wang, Liang
Zhao, Zhijun
Jia, Wei
Wang, Liru
Clinical Characteristics, Antimicrobial Resistance, and Outcomes of Patients with Invasive Pneumococcal Disease in Ningxia Hui Autonomous Region, China, 2013–2021
title Clinical Characteristics, Antimicrobial Resistance, and Outcomes of Patients with Invasive Pneumococcal Disease in Ningxia Hui Autonomous Region, China, 2013–2021
title_full Clinical Characteristics, Antimicrobial Resistance, and Outcomes of Patients with Invasive Pneumococcal Disease in Ningxia Hui Autonomous Region, China, 2013–2021
title_fullStr Clinical Characteristics, Antimicrobial Resistance, and Outcomes of Patients with Invasive Pneumococcal Disease in Ningxia Hui Autonomous Region, China, 2013–2021
title_full_unstemmed Clinical Characteristics, Antimicrobial Resistance, and Outcomes of Patients with Invasive Pneumococcal Disease in Ningxia Hui Autonomous Region, China, 2013–2021
title_short Clinical Characteristics, Antimicrobial Resistance, and Outcomes of Patients with Invasive Pneumococcal Disease in Ningxia Hui Autonomous Region, China, 2013–2021
title_sort clinical characteristics, antimicrobial resistance, and outcomes of patients with invasive pneumococcal disease in ningxia hui autonomous region, china, 2013–2021
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763006/
https://www.ncbi.nlm.nih.gov/pubmed/36545503
http://dx.doi.org/10.1155/2022/1262884
work_keys_str_mv AT taojia clinicalcharacteristicsantimicrobialresistanceandoutcomesofpatientswithinvasivepneumococcaldiseaseinningxiahuiautonomousregionchina20132021
AT wangwen clinicalcharacteristicsantimicrobialresistanceandoutcomesofpatientswithinvasivepneumococcaldiseaseinningxiahuiautonomousregionchina20132021
AT ligang clinicalcharacteristicsantimicrobialresistanceandoutcomesofpatientswithinvasivepneumococcaldiseaseinningxiahuiautonomousregionchina20132021
AT wanglinlin clinicalcharacteristicsantimicrobialresistanceandoutcomesofpatientswithinvasivepneumococcaldiseaseinningxiahuiautonomousregionchina20132021
AT wangliang clinicalcharacteristicsantimicrobialresistanceandoutcomesofpatientswithinvasivepneumococcaldiseaseinningxiahuiautonomousregionchina20132021
AT zhaozhijun clinicalcharacteristicsantimicrobialresistanceandoutcomesofpatientswithinvasivepneumococcaldiseaseinningxiahuiautonomousregionchina20132021
AT jiawei clinicalcharacteristicsantimicrobialresistanceandoutcomesofpatientswithinvasivepneumococcaldiseaseinningxiahuiautonomousregionchina20132021
AT wangliru clinicalcharacteristicsantimicrobialresistanceandoutcomesofpatientswithinvasivepneumococcaldiseaseinningxiahuiautonomousregionchina20132021